Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | 0.00% | 0.00% |
12/04 | North American Morning Briefing : Big Banks Kick -2- | DJ |
21/03 | North American Morning Briefing : Investors -2- | DJ |
Business Summary
Number of employees: 125
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 18 | 100.0 % | 50 | 100.0 % | +184.10% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 18 | 100.0 % | 50 | 100.0 % | +184.10% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sergio Alegre
CMP | Compliance Officer | - | 01/16/01 |
James Schaub
COO | Chief Operating Officer | 42 | 01/16/01 |
Michael Depetris
AUD | Comptroller/Controller/Auditor | - | 18/22/18 |
Jarret Miller
HRO | Human Resources Officer | - | 01/16/01 |
General Counsel | 60 | 01/13/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Cowan
BRD | Director/Board Member | 70 | 01/19/01 |
Alisa Lask
BRD | Director/Board Member | 53 | 10/22/10 |
Michael DeBiasi
BRD | Director/Board Member | 48 | 01/19/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 111,406,043 | 107,306,425 ( 96.32 %) | 0 | 96.32 % |
Company contact information
RVL Pharmaceuticals Plc
400 Crossing Boulevard
08807, Bridgewater
+908 809 1300
http://www.rvlpharma.comSector
1st Jan change | Capi. | |
---|---|---|
0.00% | 111 | |
-3.45% | 87.17B | |
+2.76% | 40.1B | |
-16.98% | 31.38B | |
+57.86% | 25.12B | |
-16.24% | 15.59B | |
-9.12% | 12B | |
-42.56% | 11.8B | |
-17.10% | 11.8B | |
+6.89% | 8.81B |
- Stock Market
- Equities
- RVLPQ Stock
- Company RVL Pharmaceuticals plc